The Prognostic Significance of Measurable (“Minimal”) Residual Disease in Acute Myeloid Leukemia

被引：0
|
作者：
Francesco Buccisano
Christopher S. Hourigan
Roland B. Walter
机构：
[1] University Tor Vergata,Department of Biomedicine and Prevention, Hematology
[2] National Institutes of Health,Myeloid Malignancies Section, Hematology Branch, National Heart, Lung, and Blood Institute
[3] Fred Hutchinson Cancer Research Center,Clinical Research Division
[4] University of Washington,Department of Medicine, Division of Hematology
[5] University of Washington,Department of Epidemiology
来源：
Current Hematologic Malignancy Reports | 2017年 / 12卷
关键词：
Acute myeloid leukemia; Flow cytometry; Minimal residual disease; Next-generation sequencing; Polymerase chain reaction; Prognostication;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：547 / 556
页数：9
相关论文
共 50 条
  • [31] THE PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
    Samra, A.
    Kamel, M.
    El Sharkawy, M.
    El Fatah, M. Abd
    Ghaleb, M.
    Kamel, M.
    Abdelhamid, Th.
    Elemary, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 564 - 564
  • [32] Minimal Residual Disease Quantitation in Acute Myeloid Leukemia
    Shook, David
    Coustan-Smith, Elaine
    Ribeiro, Raul C.
    Rubnitz, Jeffrey E.
    Campana, Dario
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S281 - S285
  • [33] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Jongen-Lavrencic, M.
    Grob, T.
    Hanekamp, D.
    Kavelaars, F. G.
    al Hinai, A.
    Zeilemaker, A.
    Erpelinck-Verschueren, C. A. J.
    Gradowska, P. L.
    Meijer, R.
    Cloos, J.
    Biemond, B. J.
    Graux, C.
    Kooy, M. van Marwijk
    Manz, M. G.
    Pabst, T.
    Passweg, J. R.
    Havelange, V.
    Ossenkoppele, G. J.
    Sanders, M. A.
    Schuurhuis, G. J.
    Lowenberg, B.
    Valk, P. J. M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1189 - 1199
  • [34] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Mauvieux, Laurent
    Miguet, Laurent
    Fornecker, Luc
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2442 - +
  • [35] Monitoring of minimal residual disease in acute myeloid leukemia
    Kern, W
    Schoch, C
    Haferlach, T
    Schnittger, S
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2005, 56 (02) : 283 - 309
  • [36] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA PATIENTS
    Van der Velden, Vincent
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
  • [37] Monitoring of minimal residual disease in acute myeloid leukemia
    Kern, Wolfgang
    Haferlach, Claudia
    Haferlach, Torsten
    Schnittger, Susanne
    CANCER, 2008, 112 (01) : 4 - 16
  • [38] Introducing minimal residual disease in acute myeloid leukemia
    Ofran, Yishai
    Rowe, Jacob M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 139 - 145
  • [39] Minimal residual disease in patients with acute myeloid leukemia
    Galtseva, IV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (01): : 10 - 11
  • [40] Assessment of minimal residual disease in acute myeloid leukemia
    Grimwade, David
    Vyas, Paresh
    Freeman, Sylvie
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) : 656 - 663
12345